The patent for Abilify currently expires in October 2014. This is the earliest possible date that a generic version of Abilify could become available. However, there are other circumstances that...
These are single issue movements which can be contrasted with movements that are long term and involve more than one issue. There is no single organization that controls or guides such movements.